Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
Alzamend Neuro
ALZN
Alzamend Neuro
Alzamend Neuro's Novel Lithium Formulation Will Target Major Mental Health Challenges
JA
jacopo22295
Invested
Community Contributor
Published
16 Aug 25
Updated
27 Aug 25
1
Set Fair Value
1
votes
Share
jacopo22295
's Fair Value
US$12.00
79.7% undervalued
intrinsic discount
27 Aug
US$2.44
1Y
-89.3%
7D
4.3%
Loading
1Y
-89.3%
7D
4.3%
Author's Valuation
US$12.0
79.7% undervalued
intrinsic discount
jacopo22295's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
jacopo22295
's
Fair Value
US$12.0
79.7% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
-15m
0
2016
2019
2022
2025
2028
2030
Revenue US$0
Earnings US$0
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
70.21%
Biotech revenue growth rate
11.84%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$0
Earnings '30
x
29.37x
PE Ratio '30
=
US$0
Market Cap '30
US$0
Market Cap '30
/
10.75m
No. shares '30
=
US$0
Share Price '30
US$0
Share Price '30
Discounted to 2025 @ 17.00% p.a.
=
US$0
Fair Value '25
